Scientific Perspectives on Extending the Provision for Waivers of In vivo Bioavailability and Bioequivalence Studies for Drug Products Containing High Solubility-Low Permeability D...

Por Stavchansky, Salomon
Publicado em 2008

Characterization of Nanoporous Surfaces as Templates for Drug Delivery Devices

Por Rastogi, Ashish, Bose, Tanushree, Feldman, Marc D., Patel, Devang, Stavchansky, Salomon
Publicado em 2009

Erratum to: Characterization of Nanoporous Surfaces as Templates for Drug Delivery Devices

Por Rastogi, Ashish, Bose, Tanushree, Feldman, Marc D., Patel, Devang, Stavchansky, Salomon
Publicado em 2009

Time Course Expression Analysis of 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole Induction of Cytoprotection in Human Endothelial Cells

Por Bynum, James A, Wang, Xinyu, Stavchansky, Salomon A, Bowman, Phillip D
Publicado no Gene Regul Syst Bio (2017)

The Use of BDDCS in Classifying the Permeability of Marketed Drugs()

Por Benet, Leslie Z., Amidon, Gordon L., Barends, Dirk M., Lennernäs, Hans, Polli, James E., Shah, Vinod P., Stavchansky, Salomon A., Yu, Lawrence X.
Publicado em 2008

Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Assuring Therapeutic Equivalence of Modified Release Products: Workshop Summary Report

Por Chen, Mei-Ling, Shah, Vinod P., Ganes, Derek, Midha, Kamal K., Caro, James, Nambiar, Prabu, Rocci, Mario L., Thombre, Avinash G., Abrahamsson, Bertil, Conner, Dale, Davit, Barbara, Fackler, Paul, Farrell, Colm, Gupta, Suneel, Katz, Russell, Mehta, Mehul, Preskorn, Sheldon H., Sanderink, Gerard, Stavchansky, Salomon, Temple, Robert, Wang, Yaning, Winkle, Helen, Yu, Lawrence
Publicado em 2010